» Articles » PMID: 36696904

Investigation of Osteoclast Cathepsin K Activity in Osteoclastogenesis and Bone Loss Using a Set of Chemical Reagents

Overview
Journal Cell Chem Biol
Publisher Cell Press
Specialty Biochemistry
Date 2023 Jan 25
PMID 36696904
Authors
Affiliations
Soon will be listed here.
Abstract

Cathepsin K (CatK) is a lysosomal cysteine protease whose highest expression is found in osteoclasts, which are the cells responsible for bone resorption. Investigations of the functions and physiological relevance of CatK have often relied on antibody-related techniques, which makes studying its activity patterns a challenging task. Hence, we developed a set of chemical tools for the investigation of CatK activity. We show that our probe is a valuable tool for monitoring the proteolytic activation of CatK during osteoclast formation. Moreover, we demonstrate that our inhibitor of CatK impedes osteoclastogenesis and bone resorption and that CatK is stored in its active form in osteoclasts within their lysosomal compartment and mainly in the ruffled borders of osteoclasts. Given that our probe recognizes active CatK within living cells without exhibiting any observed cytotoxicity in the several models tested, we expect that it would be well suited to theranostic applications in CatK-related diseases.

Citing Articles

Development and Application of Reversible and Irreversible Covalent Probes for Human and Mouse Cathepsin-K Activity Detection, Revealing Nuclear Activity.

Dey G, Sinai-Turyansky R, Yakobovich E, Merquiol E, Loboda J, Sridharan N Adv Sci (Weinh). 2024; 11(38):e2401518.

PMID: 38970171 PMC: 11481179. DOI: 10.1002/advs.202401518.


Cinnamaldehyde attenuates streptozocin-induced diabetic osteoporosis in a rat model by modulating netrin-1/DCC-UNC5B signal transduction.

Ji S, Zhao B, Gao Y, Xie J, Han H, Wu Q Front Pharmacol. 2024; 15:1367806.

PMID: 38628640 PMC: 11019308. DOI: 10.3389/fphar.2024.1367806.


The protective role of CD73 in periodontitis: preventing hyper-inflammatory fibroblasts and driving osteoclast energy metabolism.

Ramos-Junior E, Dawson S, Ryan W, Clinebell B, Serrano-Lopez R, Russell M Front Oral Health. 2023; 4:1308657.

PMID: 38152410 PMC: 10751373. DOI: 10.3389/froh.2023.1308657.